231 related articles for article (PubMed ID: 16818930)
1. Good enough: a primer on the analysis and interpretation of noninferiority trials.
Kaul S; Diamond GA
Ann Intern Med; 2006 Jul; 145(1):62-9. PubMed ID: 16818930
[TBL] [Abstract][Full Text] [Related]
2. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
Kaul S; Diamond GA
Prog Cardiovasc Dis; 2007; 49(4):284-99. PubMed ID: 17185116
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Merits and Drawbacks of Noninferiority Trials in Cardiovascular Medicine.
Kaul S
Can J Cardiol; 2021 Sep; 37(9):1378-1393. PubMed ID: 34118378
[TBL] [Abstract][Full Text] [Related]
4. An orwellian discourse on the meaning and measurement of noninferiority.
Diamond GA; Kaul S
Am J Cardiol; 2007 Jan; 99(2):284-7. PubMed ID: 17223435
[TBL] [Abstract][Full Text] [Related]
5. Alternatives for discounting in the analysis of noninferiority trials.
Snapinn SM
J Biopharm Stat; 2004 May; 14(2):263-73. PubMed ID: 15206525
[TBL] [Abstract][Full Text] [Related]
6. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
Hung HM; Wang SJ; O'Neill R
J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based medicine: the design and interpretation of noninferiority clinical trials in veterinary medicine.
Freise KJ; Lin TL; Fan TM; Recta V; Clark TP
J Vet Intern Med; 2013; 27(6):1305-17. PubMed ID: 24128266
[TBL] [Abstract][Full Text] [Related]
8. Non-inferiority Trial Design in Drug Development: A Primer for Cardiovascular Healthcare Professionals.
Angeli F; Verdecchia P; Reboldi G
Am J Cardiovasc Drugs; 2020 Jun; 20(3):229-238. PubMed ID: 31650521
[TBL] [Abstract][Full Text] [Related]
9. Assessing treatment efficacy in noninferiority trials.
Wang SJ; Hung HM
Control Clin Trials; 2003 Apr; 24(2):147-55. PubMed ID: 12689736
[TBL] [Abstract][Full Text] [Related]
10. Test for the consistency of noninferiority from multiple clinical trials.
Yan X; Wang MC; Su X
J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
[TBL] [Abstract][Full Text] [Related]
11. Randomization as a basis for inference in noninferiority trials.
Wiens BL
Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
[TBL] [Abstract][Full Text] [Related]
12. Hypotheses and type I error in active-control noninferiority trials.
Chen G; Wang YC; Chi GY
J Biopharm Stat; 2004 May; 14(2):301-13. PubMed ID: 15206528
[TBL] [Abstract][Full Text] [Related]
13. [Noninferiority trials: several simple principles].
Vicaut E; Cucherat M
Presse Med; 2007 Mar; 36(3 Pt 2):531-5. PubMed ID: 17289337
[TBL] [Abstract][Full Text] [Related]
14. Avoiding ambiguity with the Type I error rate in noninferiority trials.
Kang SH
J Biopharm Stat; 2016; 26(3):452-65. PubMed ID: 26252624
[TBL] [Abstract][Full Text] [Related]
15. Placebo or active control trials of antipsychotic drugs?
Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
[TBL] [Abstract][Full Text] [Related]
16. Noninferiority Studies with Multiple New Treatments and Heterogeneous Variances.
Huang LC; Wen MJ; Cheung SH
J Biopharm Stat; 2015; 25(5):958-71. PubMed ID: 24918478
[TBL] [Abstract][Full Text] [Related]
17. Choice of delta noninferiority margin and dependency of the noninferiority trials.
Tsong Y; Zhang J; Levenson M
J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
[TBL] [Abstract][Full Text] [Related]
18. Statistical issues on objective, design, and analysis of noninferiority active-controlled clinical trial.
Tsong Y; Wang SJ; Hung HM; Cui L
J Biopharm Stat; 2003 Feb; 13(1):29-41. PubMed ID: 12635901
[TBL] [Abstract][Full Text] [Related]
19. Bayesian approach to noninferiority trials for proportions.
Gamalo MA; Wu R; Tiwari RC
J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
[TBL] [Abstract][Full Text] [Related]
20. Reporting of noninferiority trials was incomplete in trial registries.
Dekkers OM; Soonawala D; Vandenbroucke JP; Egger M
J Clin Epidemiol; 2011 Sep; 64(9):1034-8. PubMed ID: 21444195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
